Clinical Trial Update: Extension Study Evaluating Long Term Safety and Activity of AGT-181 in Children With MPS I [Phase 1, Phase 2]

View source ↗

Summary

Extension study evaluating long-term safety and activity of AGT-181 in children with MPS I completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mucopolysaccharidosis

Drugs mentioned

• AGT-181

Snippet

Sponsor: ArmaGen, Inc | Conditions: Mucopolysaccharidosis I | Phase 1, Phase 2 | Status: COMPLETED